TrialCancer biology & therapy2015

A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes.

Qiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.